Category: pharma & healthcare

As BioMarin turns to commercialization of Roctavian, we will likely hear more about how warranties could help gene therapies overcome payer reimbursement hurdles.

Activists Howard and Norma Lotsof devote their lives to the study of ibogaine to help people with addiction and mental illness. Director Lucy Walker humanizes suffering.

As one of the most primitive parts of our nervous system, the vagus nerve controls many aspects of the body that are outside our conscious control.

Viroids and virusoids are the smallest known pathogens. They have traditionally been considered fairly uncommon; new research challenges this assumption.

Advances in wearable sensor technology may improve health outcomes for those at risk of mobility limitation later in life.

The future of cancer treatment may involve two modern technologies: mRNA and CAR T Therapy. Here, we describe an example using multiple myeloma.

This article will discuss some of the most promising gene therapies for age-related macular degeneration, including ADVM-022, RGX-314, GT-005, and HMR59.

Advances in MRI microstructure biomarker identification may help stop long-term brain injury in athletes before it’s too late.

Restrictive abortion laws cause clinicians, pharmacies to refuse non-pregnant women access to drugs they need to treat medical conditions.

Contrary to previous assumptions, hepatitis D virus-like agents seem to be active in a range of different animal species, from fish all the way to termites.